These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 39148124)

  • 1. Palmitoyltransferase ZDHHC6 promotes colon tumorigenesis by targeting PPARγ-driven lipid biosynthesis via regulating lipidome metabolic reprogramming.
    Shan J; Li X; Sun R; Yao Y; Sun Y; Kuang Q; Dai X; Sun Y
    J Exp Clin Cancer Res; 2024 Aug; 43(1):227. PubMed ID: 39148124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma.
    Ning Z; Guo X; Liu X; Lu C; Wang A; Wang X; Wang W; Chen H; Qin W; Liu X; Zhou L; Ma C; Du J; Lin Z; Luo H; Otkur W; Qi H; Chen D; Xia T; Liu J; Tan G; Xu G; Piao HL
    Nat Commun; 2022 Apr; 13(1):2187. PubMed ID: 35449157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.
    Noh KH; Kang HM; Yoo W; Min Y; Kim D; Kim M; Wang S; Lim JH; Jung CR
    Metabolism; 2020 Sep; 110():154302. PubMed ID: 32589900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
    Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
    Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
    Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
    J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
    Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
    Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and dynamics of the human ZDHHC16-ZDHHC6 palmitoylation cascade.
    Abrami L; Dallavilla T; Sandoz PA; Demir M; Kunz B; Savoglidis G; Hatzimanikatis V; van der Goot FG
    Elife; 2017 Aug; 6():. PubMed ID: 28826475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of fatty acid oxidation by involvement of HIF-1α and PPARγ in human gastric adenocarcinoma and related clinical significance.
    Ezzeddini R; Taghikhani M; Salek Farrokhi A; Somi MH; Samadi N; Esfahani A; Rasaee MJ
    J Physiol Biochem; 2021 May; 77(2):249-260. PubMed ID: 33730333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of SDHC promotes metastasis by reprogramming fatty acid metabolism in colorectal cancer.
    Ding Z; Wei Y; Dai J; Pan C; Yang L; Li Q; Zhang Y; Yan Q; Wu C; Li A; Lan Z; Liu S; Wang X
    J Transl Med; 2024 Jun; 22(1):544. PubMed ID: 38844980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study.
    Cui H; Jin Y; Wang N; Liu H; Shu R; Wang J; Wang X; Jia B; Wang Y; Bian Y; Wen W
    Phytomedicine; 2024 Jun; 128():155509. PubMed ID: 38452403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
    Milone MR; Pucci B; Colangelo T; Lombardi R; Iannelli F; Colantuoni V; Sabatino L; Budillon A
    Mol Oncol; 2016 Oct; 10(8):1344-62. PubMed ID: 27499265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artemisinin inhibits NRas palmitoylation by targeting the protein acyltransferase ZDHHC6.
    Qiu N; Abegg D; Guidi M; Gilmore K; Seeberger PH; Adibekian A
    Cell Chem Biol; 2022 Mar; 29(3):530-537.e7. PubMed ID: 34358442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms.
    Elix CC; Salgia MM; Otto-Duessel M; Copeland BT; Yoo C; Lee M; Tew BY; Ann D; Pal SK; Jones JO
    Prostate; 2020 Feb; 80(2):162-172. PubMed ID: 31769890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ.
    Alex S; Lange K; Amolo T; Grinstead JS; Haakonsson AK; Szalowska E; Koppen A; Mudde K; Haenen D; Al-Lahham S; Roelofsen H; Houtman R; van der Burg B; Mandrup S; Bonvin AM; Kalkhoven E; Müller M; Hooiveld GJ; Kersten S
    Mol Cell Biol; 2013 Apr; 33(7):1303-16. PubMed ID: 23339868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocyte Elevated Gene-1 Cys75
    Komaniecki G; Camarena MDC; Gelsleichter E; Mendoza R; Subler M; Windle JJ; Dozmorov MG; Lai Z; Sarkar D; Lin H
    Biochemistry; 2023 Jan; 62(2):543-553. PubMed ID: 36548985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Peroxisome Proliferator-Activated Receptor (PPAR)-
    Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
    Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPARγ in gastric cancer.
    Cheng Y; Jia B; Wang Y; Wan S
    Oncol Rep; 2017 Nov; 38(5):3220-3226. PubMed ID: 28901466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells.
    Schaefer KL; Takahashi H; Morales VM; Harris G; Barton S; Osawa E; Nakajima A; Saubermann LJ
    Int J Cancer; 2007 Feb; 120(3):702-13. PubMed ID: 17096328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.
    Colangelo T; Fucci A; Votino C; Sabatino L; Pancione M; Laudanna C; Binaschi M; Bigioni M; Maggi CA; Parente D; Forte N; Colantuoni V
    Neoplasia; 2013 Sep; 15(9):1086-99. PubMed ID: 24027433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.
    Dai Y; Qiao L; Chan KW; Yang M; Ye J; Ma J; Zou B; Gu Q; Wang J; Pang R; Lan HY; Wong BC
    Cancer Res; 2009 Jun; 69(11):4776-83. PubMed ID: 19458067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.